Nine digital health companies have been selected for the inaugural cohort of Grow Digital Health Midlands, a regional accelerator focused on scaling healthcare technology across the NHS and broader care system.
Launched in early 2025 as the successor to the East Midlands Digital Health Accelerator, the programme is delivered by Health Innovation East Midlands and Health Innovation West Midlands. It targets high-potential digital solutions that align with national NHS priorities and specific regional challenges, particularly those aimed at improving workforce productivity, enhancing communication, and reducing pressure on hospital services.
The selected companies will receive tailored support, including one-on-one business coaching and access to clinical, regulatory, and commercial expertise. They will also have opportunities to present their technologies directly to NHS stakeholders and care leaders across the Midlands.
The cohort includes Appthealth, which automates care coordination for patients with multiple long-term conditions, and Hope for the Community, which provides digital self-management tools for individuals with chronic illnesses and their carers. AirEmail offers a platform to improve email workflows for healthcare professionals, while Kaenect delivers AI-powered referral automation and patient engagement tools. Surgfit supports remote pre-operative assessment to enhance clinical decision-making, and Heidi Health enables automatic medical transcription to reduce clinician admin. Suvera operates virtual clinics to improve primary care outcomes for patients with long-term conditions. ExpertCare focuses on personalised decision support for hypertension, and Note Dr provides AI-generated clinical documentation in real time.
The Midlands, which spans 11 integrated care systems and a population of nearly 12 million, is the largest NHS region in England. The programme was developed in close consultation with local NHS leaders to ensure each selected solution aligns with regional goals and demonstrates high potential for real-world adoption.
